Amgen Inc. (NASDAQ:AMGN) is one of the These 10 Stocks Took A Shocking Fall. Amgen Inc. extended its losing streak to a ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

To get a sense of who is truly in control of Amgen Inc. (NASDAQ:AMGN), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company ...

Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Amgen's MariTide showed strong weight loss and metabolic gains in Phase 2, with no new safety signals as Phase 3 trials begin in obesity and T2D.

Retired pro football hall-of-famer Barry Sanders revealed he had a heart attack in 2024. But now he working to help other ...

Thousand Oaks, California Wednesday, June 25, 2025, 13:00 Hrs [IST] ...

In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...

Last spring, drugmaker Amgen Inc. announced plans to buy  Microsoft Corp.’s Copilot AI assistant for 20,000 employees. It was ...

A Bloomberg report has claimed even businesses which have purchased Copilot plans are struggling to convince users to make the switch, with drugmaker Amgen buying a 20,000 user plan, only to have ...